En español
NIDA

Medications to Treat Opioid Addiction

Access to Naloxone

Naloxone is an opioid antagonist that can reverse an opioid overdose. Naloxone access increased between 2010 and 2014, with:8

  • more than three times the number of local sites providing naloxone (from 188 to 644)
  • nearly three times the number of laypersons provided naloxone kits (from 53,032 to 152,283)
  • a 94 percent increase in states (from 16 to 30), including Washington, DC, with at least one organization providing naloxone
  • more than 2.5 times the number of overdose reversals reported (from 10,171 to 26,463)

Naloxone prescriptions dispensed from retail pharmacies increased nearly twelvefold between the fourth quarter of 2013 and the second quarter of 2015.111

Many states have passed laws to widen the availability to naloxone for family, friends, and other potential bystanders of overdose.

Image showing state naloxone and good Samaritan laws as of October 2017. 43 states have standing orders to authorize nonmedical personnel to issue naloxone. 34 states protect naloxone prescribers from both criminal and civil liability. 10 states offer legal protection to those who call 911 to report an overdose. Image courtesy of PDAPS.

Naloxone has become widely used by emergency medical providers, with all 50 states and the District of Columbia, Guam, and Puerto Rico certifying and approving emergency medical service personnel at the paramedic level to administer naloxone. One step further, emergency medical technicians (EMTs) were explicitly permitted to administer naloxone in 12 of these 53 jurisdictions (23 percent—California, Colorado, District of Columbia, Massachusetts, Maryland, New Mexico, North Carolina, Ohio, Oklahoma, Rhode Island, Virginia, and Vermont) as of November 2013. Because nonparamedic EMTs are typically the first and sometimes only source of emergency care, providing authorization and training for them to administer naloxone is a promising strategy to reduce overdose deaths.112 

After a naloxone training session, a majority of police officers reported that it would not be difficult to use naloxone at the scene of an overdose (89.7 percent) and that it was important that other officers be trained to use naloxone (82.9 percent).113

Effects of Naloxone Distribution

Overdose education and naloxone distribution (OEND) has been shown to increase the reversal of potentially fatal overdoses; one study showed opioid overdose death rates to be 27 to 46 percent lower in communities where OEND was implemented.114 Among 4,926 people who used substances and participated in OEND in Massachusetts, 373 (7.6 percent) reported administering naloxone during an overdose rescue, with few differences in behavior between trained and untrained overdose rescuers.115 A naloxone distribution study in San Francisco reported that 11 percent of participants used naloxone during an overdose; of 399 overdose events where naloxone was used, 89 percent were reversed.116 Brief education is sufficient to improve comfort and competence in recognizing and managing overdose.117 Prospective studies are needed to determine the optimal level of training and whether naloxone rescue kits can meet the standard for becoming available over the counter.115

In a probabilistic analysis, naloxone distribution programs were shown to prevent overdose deaths, increase quality-adjusted life years (QALYs) and be highly cost-effective. Naloxone distribution was predicted to prevent 6 percent of overdose deaths, 1 for every 227 naloxone kits distributed. Cost effectiveness, under markedly conservative predictions, was measured to be $14,000.00 per QALY, well within the standard favorable range of cost-benefit ratios (under $50,000.00 per QALY).118

Critics of naloxone distribution have claimed that it could lead to an increase in risky opioid use, but a study in Massachusetts showed rates of opioid-related visits to an emergency department and hospital admission were not significantly different in communities with low or high implementation of OEND programs.114

This page was last updated May 2017

Get this Publication

Cite this article

NIDA. (2017, May 25). Medications to Treat Opioid Addiction. Retrieved from https://www.drugabuse.gov/publications/research-reports/medications-to-treat-opioid-addiction

press ctrl+c to copy
NIDAMED Logo
NIDA Notes: The Latest in Drug Abuse Research

​Research Reports

This series of reports simplifies the science of research findings for the educated lay public, legislators, educational groups, and practitioners. The series reports on research findings of national interest.

Lesson Plan and Activity Finder